Albert Font
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
Papers in
-
- Prostate Cancer Treatment and Research 33
- Lung Cancer Treatments and Mutations 11
- Oncology 41
- Cancer Immunotherapy and Biomarkers 11
- Cancer Treatment and Pharmacology 9
- Co-authors
- Vicenç Ruiz de Porras (14 shared papers)Rafael Rosell (9 shared papers)Johann S. de Bono (5 shared papers)Mariano Monzó (4 shared papers)Àlex Pifarré (4 shared papers)Rafael Rosell (6 shared papers)Isabel Ojanguren (3 shared papers)Joan Carles (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (10 papers)Clinical Cancer Research (3 papers)European Journal of Cancer (3 papers)Cancers (3 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Albert Font
70 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 874
- Oncology 720
- Cancer Research 381
- Internal Medicine 47
- Pathology and Forensic Medicine 216
Countries citing papers authored by Albert Font
This map shows the geographic impact of Albert Font's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Font with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Font more than expected).
Fields of papers citing papers by Albert Font
This network shows the impact of papers produced by Albert Font. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Font. The network helps show where Albert Font may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Font, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 227 | |
| 2 | 2017 | 163 | |
| 3 | 2014 | 123 | |
| 4 | 1998 | 113 | |
| 5 | 2010 | 107 | |
| 6 | 2013 | 54 | |
| 7 | 2001 | 54 | |
| 8 | 2014 | 49 | |
| 9 | 2003 | 48 | |
| 10 | 2020 | 45 | |
| 11 | 2021 | 43 | |
| 12 | 2016 | 40 | |
| 13 | 2009 | 39 | |
| 14 | 2020 | 35 | |
| 15 | 2020 | 34 | |
| 16 | 2004 | 32 | |
| 17 | 2022 | 31 | |
| 18 | 2022 | 29 | |
| 19 | 1996 | 27 | |
| 20 | 2016 | 25 |
About Albert Font
Albert Font is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Bladder and Urothelial Cancer Treatments (13 papers), Urinary and Genital Oncology Studies (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer, Lipids, and Metabolism (10 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (874 citations), Oncology (720 citations), Cancer Research (381 citations), Internal Medicine (47 citations) and Pathology and Forensic Medicine (216 citations). Albert Font has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Vicenç Ruiz de Porras, Rafael Rosell, Johann S. de Bono, Mariano Monzó, Àlex Pifarré, Rafael Rosell, Isabel Ojanguren, Joan Carles, Steven Gendreau and Kent C. Shih. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.